Petrovax aims at building up its international partnership and export potential. To implement its innovative strategy, the company cooperates with leading research institutes, Russian and international partners for the development of new products, technology transfer, and
In partnership with Abbott (former Solvay Pharma), Petrovax successfully completed the construction of an
Petrovax, jointly with Pfizer, delivered a localization project to implement a
Since 2014, this vaccine has been procured for the Russian national Immunization Schedule.
Petrovax implemented the first in the Russian history localization project to manufacture Russian original influenza vaccine Grippol® plus in Belarus under agreement with the Ministry of Health of Belarus, and RUE Belmedpreparaty.
Petrovax established a partnership with Boehringer Ingelheim to localize
Petrovax made a